NCT07059832View on ClinicalTrials.gov

Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

January 1, 2028

Study Completion Date

April 1, 2028

Conditions
Cancer
Interventions
DRUG

68Ga-NODAGA-SNA006

68Ga-NODAGA-SNA006 PET/CT: after intravenous injection of 0.05 mCi/kg body weight of quality-controlled 68Ga-NODAGA-SNA006, an integrated PET/CT scanner (Biograph mCT; Siemens, Germany) will be applied.

Trial Locations (1)

Unknown

The First Hospital of China Medical University, Shenyang

All Listed Sponsors
lead

First Hospital of China Medical University

OTHER

NCT07059832 - Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors | Biotech Hunter | Biotech Hunter